pharma · Multiple Myeloma · Recurrent glioblastoma
Oncopeptides AB (publ)
Oncopeptides AB (publ) patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Stockholm, SE HQ
2000 Founded
85 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Stockholm, SE
- Founded
- 2000
- Employees
- 85
- Programs
- 2
- Drugs
- 2
- Patents
- 0
Oncopeptides AB (publ) patents
0 pharmaceutical patents indexed for Oncopeptides AB (publ). 0 expire within 24 months.
Oncopeptides AB (publ) has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Oncopeptides AB (publ) have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Oncopeptides AB (publ) patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.